1932

Abstract

The development of genetic and serological markers of autoimmune Type I diabetes has allowed us to begin to identify subjects at risk for the development of Type I diabetes. Assessment of these variables can assign risk to subjects and permit the implementation of immune intervention trials in an attempt to alter the course of pre-diabetes. This review discusses relevant aspects of the genetics and diagnosis of pre-diabetes, and both current and future clinical trials that are attempting to prevent the full expression of clinical diabetes in these individuals.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.49.1.391
1998-02-01
2024-04-14
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.49.1.391
Loading
/content/journals/10.1146/annurev.med.49.1.391
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error